Brief: Aspira Women’S Health Reports Q3 2022 Results
Nov 10 (Reuters) - Aspira Women's Health Inc AWH.O :
* ASPIRA WOMEN’S HEALTH REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* ASPIRA WOMEN'S HEALTH INC - REITERATE OUR INTENTION TO
LAUNCH
OVAWATCH IN Q4 OF 2022
* ASPIRA WOMEN'S HEALTH INC QTRLY TOTAL REVENUE $2.1 MILLION
VERSUS $1.7 MILLION
* ASPIRA WOMEN'S HEALTH INC QTRLY NET LOSS PER SHARE - BASIC
AND
DILUTED $0.04
Source text for Eikon: ID:nGNX94PtpF
Further company coverage: AWH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aspira Women's Health
See all newsBrief: Aspira Women’S Health Announces Receipt Of Delisting Notification From Nasdaq
Brief: Aspira Women's Health On April 4, Enters Equity Purchase Agreement With Triton Funds
Brief: Aspira Women's Health Files For Offering Up To 50 Units, 50 Mln Pre-Funded Units
Brief: Aspira Women's Health Interim CFO John Kallassy Resigns
Brief: Aspira Women's Health Fails To Regain Nasdaq Compliance